Chapter 7 - Preparation of complexes of liposomes with gold nanoparticles. 2009

Chie Kojima, and Yusuke Hirano, and Kenji Kono
Nanoscience and Nanotechnology Research Center, Research Institutes for the Twenty First Century, Osaka Prefecture University, Osaka, Japan.

Liposomes have been widely used as drug carriers. Visible liposomes have recently become more attractive as drug carriers in personalized medicine. Gold nanoparticles (Au NPs) have unique size- and shape-dependent properties based on their surface plasmon resonance. They can be visualized by computed tomography (CT) and laser optoacoustic imaging. In addition, their photothermogenic properties are useful for photothermal therapy and photoresponsive drug release from liposomes. Therefore, complexation of liposomes with Au NPs is of considerable interest. There are three types of complex: Liposomes containing Au NPs in the inner phase, liposomes with Au NPs at the lipid membrane, and liposomes modified with Au NPs on the surface. This chapter focuses on the preparation and characterization of the third type of complex that is prepared by direct mixing of a Au NP dispersion with a liposome suspension.

UI MeSH Term Description Entries
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D006046 Gold A yellow metallic element with the atomic symbol Au, atomic number 79, and atomic weight 197. It is used in jewelry, goldplating of other metals, as currency, and in dental restoration. Many of its clinical applications, such as ANTIRHEUMATIC AGENTS, are in the form of its salts.
D053768 Metal Nanoparticles Nanoparticles produced from metals whose uses include biosensors, optics, and catalysts. In biomedical applications the particles frequently involve the noble metals, especially gold and silver. Metal Nanocrystals,Metallic Nanocrystals,Metallic Nanoparticles,Metal Nanocrystal,Metal Nanoparticle,Metallic Nanocrystal,Metallic Nanoparticle,Nanocrystal, Metal,Nanocrystal, Metallic,Nanocrystals, Metal,Nanocrystals, Metallic,Nanoparticle, Metal,Nanoparticle, Metallic,Nanoparticles, Metal,Nanoparticles, Metallic
D036103 Nanotechnology The development and use of techniques to study physical phenomena and construct structures in the nanoscale size range or smaller. Nanotechnologies

Related Publications

Chie Kojima, and Yusuke Hirano, and Kenji Kono
July 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
Chie Kojima, and Yusuke Hirano, and Kenji Kono
October 2012, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB),
Chie Kojima, and Yusuke Hirano, and Kenji Kono
October 2022, Colloids and surfaces. B, Biointerfaces,
Chie Kojima, and Yusuke Hirano, and Kenji Kono
April 2015, Journal of controlled release : official journal of the Controlled Release Society,
Chie Kojima, and Yusuke Hirano, and Kenji Kono
September 2011, Molecules (Basel, Switzerland),
Chie Kojima, and Yusuke Hirano, and Kenji Kono
February 2005, Biological & pharmaceutical bulletin,
Chie Kojima, and Yusuke Hirano, and Kenji Kono
January 2008, Dalton transactions (Cambridge, England : 2003),
Chie Kojima, and Yusuke Hirano, and Kenji Kono
December 2011, Journal of liposome research,
Chie Kojima, and Yusuke Hirano, and Kenji Kono
February 2012, Journal of photochemistry and photobiology. B, Biology,
Chie Kojima, and Yusuke Hirano, and Kenji Kono
January 2009, Journal of nanoscience and nanotechnology,
Copied contents to your clipboard!